Jeffrey Lu

Co-Founder & CEO at Engine Biosciences

Jeff is passionate about building companies using technology and science for impact. He has fifteen years of business, executive management, and entrepreneurial experience, creating sustainable businesses, shareholder value and liquidity events.

​​

In addition to Engine, Jeff has played founding and leadership roles in several biotechnology and technology companies. This includes Enleofen Bio (developing therapeutics targeting IL-11 for fibrosis; preclinical pipeline acquired by Boehringer Ingelheim for >$1 billion), PairX Bio (venture-backed cancer immunotherapy company), and AAE (travel technology company built to >$100 million revenue and profitability within three years of inception; acquired by Expedia Inc in transactions valuing AAE at ~$300 million), among others.

Jeff began his career as a management consultant at Bain & Company. Subsequently he joined AirAsia as Head of Strategy and Group Head of Commercial Strategy, leading teams covering strategy, commercial strategy, data analytics, and digital marketing. He played a principal role in establishing several new joint ventures and businesses for the group.

Jeff has been named a Young Global Leader by the World Economic Forum. He received his BA summa cum laude from University of Pennsylvania.

Links

Previous companies

AirAsia logo

Timeline

  • Co-Founder & CEO

    Current role

View in org chart